Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 8/2010

01.08.2010 | Brief Report

Antibiotic resistance in orthopaedic surgery: acute knee prosthetic joint infections due to extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae

verfasst von: J. C. Martínez-Pastor, F. Vilchez, C. Pitart, J. M. Sierra, A. Soriano

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 8/2010

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to describe the prevalence and characteristics of knee prosthetic joint infections due to extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae. From 2000 to 2007, 132 infections out of 5,076 arthroplasties (2.6%) were registered. Seven out of 132 infections (5.3%) were due to ESBL-producing Enterobacteriaceae, Escherichia coli in six cases and Klebsiella pneumoniae in one. Open debridement and retention of the implant was the first surgical approach and all patients received intravenous carbapenems. Relapse was documented in four cases and remission in three. Therefore, debridement without prosthesis removal was associated with a high failure rate.
Literatur
1.
Zurück zum Zitat Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL (2007) Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect 55:1–7CrossRefPubMed Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL (2007) Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect 55:1–7CrossRefPubMed
2.
Zurück zum Zitat Nijssen S, Florijn A, Bonten MJ, Schmitz FJ, Verhoef J, Fluit AC (2004) Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents 24:585–591CrossRefPubMed Nijssen S, Florijn A, Bonten MJ, Schmitz FJ, Verhoef J, Fluit AC (2004) Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents 24:585–591CrossRefPubMed
3.
Zurück zum Zitat Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I et al (2006) Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42:925–934CrossRefPubMed Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I et al (2006) Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42:925–934CrossRefPubMed
4.
Zurück zum Zitat Mirelis B, Navarro F, Miró E, Mesa RJ, Coll P, Prats G (2003) Community transmission of extended-spectrum beta-lactamase. Emerg Infect Dis 9:1024–1025PubMed Mirelis B, Navarro F, Miró E, Mesa RJ, Coll P, Prats G (2003) Community transmission of extended-spectrum beta-lactamase. Emerg Infect Dis 9:1024–1025PubMed
5.
Zurück zum Zitat Barberán J, Aguilar L, Carroquino G, Giménez MJ, Sánchez B, Martínez D et al (2006) Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med 119:993.e7–993.e10CrossRef Barberán J, Aguilar L, Carroquino G, Giménez MJ, Sánchez B, Martínez D et al (2006) Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med 119:993.e7–993.e10CrossRef
6.
Zurück zum Zitat Soriano A, García S, Bori G, Almela M, Gallart X, Macule F et al (2006) Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 12:930–933CrossRefPubMed Soriano A, García S, Bori G, Almela M, Gallart X, Macule F et al (2006) Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 12:930–933CrossRefPubMed
7.
Zurück zum Zitat Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE (1998) Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA 279:1537–1541CrossRefPubMed Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE (1998) Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA 279:1537–1541CrossRefPubMed
8.
Zurück zum Zitat Brouqui P, Rousseau MC, Stein A, Drancourt M, Raoult D (1995) Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime–ciprofloxacin antibiotic combination. Antimicrob Agents Chemother 39:2423–2425PubMed Brouqui P, Rousseau MC, Stein A, Drancourt M, Raoult D (1995) Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime–ciprofloxacin antibiotic combination. Antimicrob Agents Chemother 39:2423–2425PubMed
9.
Zurück zum Zitat Legout L, Senneville E, Stern R, Yazdanpanah Y, Savage C, Roussel-Delvalez M et al (2006) Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime–fluoroquinolone combination. Clin Microbiol Infect 12:1030–1033CrossRefPubMed Legout L, Senneville E, Stern R, Yazdanpanah Y, Savage C, Roussel-Delvalez M et al (2006) Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime–fluoroquinolone combination. Clin Microbiol Infect 12:1030–1033CrossRefPubMed
10.
Zurück zum Zitat Tanaka G, Shigeta M, Komatsuzawa H, Sugai M, Suginaka H, Usui T (1999) Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents: beta-lactams and fluoroquinolones. Chemotherapy 45:28–36CrossRefPubMed Tanaka G, Shigeta M, Komatsuzawa H, Sugai M, Suginaka H, Usui T (1999) Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents: beta-lactams and fluoroquinolones. Chemotherapy 45:28–36CrossRefPubMed
11.
Zurück zum Zitat Bagge N, Schuster M, Hentzer M, Ciofu O, Givskov M, Greenberg EP et al (2004) Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. Antimicrob Agents Chemother 48:1175–1187CrossRefPubMed Bagge N, Schuster M, Hentzer M, Ciofu O, Givskov M, Greenberg EP et al (2004) Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. Antimicrob Agents Chemother 48:1175–1187CrossRefPubMed
12.
Zurück zum Zitat Jones RN, Pfaller MA (2003) Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum beta-lactamase in Europe. Clin Microbiol Infect 9:708–712CrossRefPubMed Jones RN, Pfaller MA (2003) Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum beta-lactamase in Europe. Clin Microbiol Infect 9:708–712CrossRefPubMed
Metadaten
Titel
Antibiotic resistance in orthopaedic surgery: acute knee prosthetic joint infections due to extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae
verfasst von
J. C. Martínez-Pastor
F. Vilchez
C. Pitart
J. M. Sierra
A. Soriano
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 8/2010
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-0950-y

Weitere Artikel der Ausgabe 8/2010

European Journal of Clinical Microbiology & Infectious Diseases 8/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.